{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:25:06Z","timestamp":1773660306457,"version":"3.50.1"},"reference-count":38,"publisher":"Informa UK Limited","issue":"11","license":[{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Sanofi and Regeneron Pharmaceuticals, Inc"},{"name":"Creativ-Ceutical"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Asthma"],"published-print":{"date-parts":[[2022,11,2]]},"DOI":"10.1080\/02770903.2021.1996596","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T21:44:23Z","timestamp":1636494263000},"page":"2162-2173","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Cost-effectiveness analysis of dupilumab among patients with oral corticosteroid-dependent uncontrolled severe asthma in Japan"],"prefix":"10.1080","volume":"59","author":[{"given":"Yuji","family":"Tohda,","sequence":"first","affiliation":[{"name":"Kindai University Hospital, Osakasayama, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisako","family":"Matsumoto,","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine & Allergology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Miyata,","sequence":"additional","affiliation":[{"name":"Immunology Medical, Sanofi K.K, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurie","family":"Taguchi,","sequence":"additional","affiliation":[{"name":"Health Economics and Value Assessment, Market Access, Sanofi K.K, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Ueyama,","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research, Creativ-Ceutical, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Joulain,","sequence":"additional","affiliation":[{"name":"Global Health Economics and Value Assessment, Sanofi, Chilly-Mazarin, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Arakawa,","sequence":"additional","affiliation":[{"name":"Office of Human Research Studies, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,12,8]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.09.043"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2016.12.005"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.08.015"},{"key":"CIT0004","unstructured":"Sanofi\/Regeneron Global Brand Team. Asthma Brand Plan 2018. 2017."},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.2147\/jaa.s52387"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2019.02.004"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.10.009"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2019.01.018"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1111\/all.14268"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2013.01.007"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.2165\/11598940-000000000-00000"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.3310\/hta17520"},{"key":"CIT0014","unstructured":"National Institute for Health and Care Excellence (NICE). Mepolizumab for treating severe eosinophilic asthma [ID798]. London, UK: National Institute for Health and Care Excellence; 2017 Jan [accessed 2019 October 10]. https:\/\/www.nice.org.uk\/guidance\/ta431."},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.3109\/02770903.2013.767909"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.08.726"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1703501"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403291"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2004.00772.x"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.105991"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804093"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804092"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-018-0742-y"},{"key":"CIT0025","unstructured":"Ministry of Health, Labor and Welfare. The 22nd life tables. Tokyo, Japan: Ministry of Health, Labor and Welfare [accessed 2019 Oct 10]. https:\/\/www.mhlw.go.jp\/english\/database\/db-hw\/lifetb22nd\/index.html."},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1186\/s12962-018-0089-8"},{"key":"CIT0027","unstructured":"National Institute for Health and Care Excellence (NICE). Benralizumab for treating severe eosinophilic asthma [TA565]. London, UK: National Institute for Health and Care Excellence; 2019 Sep [accessed 2019 Oct 10]. https:\/\/www.nice.org.uk\/guidance\/ta565."},{"key":"CIT0028","unstructured":"Ministry of Health, Labor and Welfare. Drug Master Search. Various information on medical fees. Tokyo, Japan: Ministry of Health, Labor and Welfare [accessed 2018 Apr]. https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000078916.html."},{"key":"CIT0029","unstructured":"Pharmaceuticals and Medical Devices Agency. Search of package inserts. Tokyo, Japan: Pharmaceuticals and Medical Devices Agency [accessed 2019 Oct 10]. http:\/\/www.info.pmda.go.jp\/psearch\/html\/menu_tenpu_base.html."},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199711000-00002"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.02.008"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X11401031"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-016-1435-y"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.10.005"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-018-0658-x"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-019-00841-1"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-019-01554-0"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2019.1668132"}],"container-title":["Journal of Asthma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/02770903.2021.1996596","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T13:18:16Z","timestamp":1666012696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/02770903.2021.1996596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,8]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,2]]}},"alternative-id":["10.1080\/02770903.2021.1996596"],"URL":"https:\/\/doi.org\/10.1080\/02770903.2021.1996596","relation":{},"ISSN":["0277-0903","1532-4303"],"issn-type":[{"value":"0277-0903","type":"print"},{"value":"1532-4303","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijas20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijas20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-03-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}